| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/28/2009 | CN101352557A Chinese medicine preparation for treating gastric cancer and preparation method thereof |
| 01/28/2009 | CN101352549A Anticancer Chinese patent medicine with functions of anti-tumor metastasis and induction of tumor cell differentiation |
| 01/28/2009 | CN101352538A Prescription and preparation technique of medicament for treating nasopharyngeal carcinoma |
| 01/28/2009 | CN101352515A Chinese medicinal composition for treating tongue cancer and preparation method thereof |
| 01/28/2009 | CN101352499A Nidaodier tablet medicine |
| 01/28/2009 | CN101352490A Anti-tumor Chinese medicine extract, and preparation method and uses thereof |
| 01/28/2009 | CN101352485A Novel uses of antiar latex and extract thereof in preparing anti-cancer medicine |
| 01/28/2009 | CN101352477A Use of ormosia seed extract in preparing anti-tumor medicament |
| 01/28/2009 | CN101352474A Uses of prickly pear and prickly pear polysaccharide in preparing medicament or health products |
| 01/28/2009 | CN101352468A Novel uses of Calotropis gigantea and extract thereof in preparing anti-tumor medicament |
| 01/28/2009 | CN101352465A Method for preparing ginseng health product medicinal granules |
| 01/28/2009 | CN101352462A Chinese actinidia root triterpenes compounds and extracting method thereof |
| 01/28/2009 | CN101352448A Use of Liriope muscari Bailey C in pharmacy |
| 01/28/2009 | CN101352445A Novel use of chuanbeinone compounds |
| 01/28/2009 | CN101352444A New use of tripterine in pharmacy |
| 01/28/2009 | CN101352439A Composition injection containing tetrandrine and preparation method thereof |
| 01/28/2009 | CN101352437A Use of amaryllidaceae alkaloid as tumour anti-apoptosis factor Mc1-1 inhibitor |
| 01/28/2009 | CN101352434A Use of triptolide in preparing medicament for treating c-KIT tyrosine kinase related tumor |
| 01/28/2009 | CN101352420A Hydroxycamptothecin sustained-release microsphere and preparation method thereof |
| 01/28/2009 | CN101352418A Pirarubicin or pirarubicin hydrochloride lipid nano granule and preparation method thereof |
| 01/28/2009 | CN101352416A Luteolin solution composition |
| 01/28/2009 | CN101352414A Compound anticancer sustained-release injection containing vascular inhibitor |
| 01/28/2009 | CN101352413A Compound anticancer sustained-release injection containing clofarabine |
| 01/28/2009 | CN101352234A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 01/28/2009 | CN101352192A Ficus carica fruit tea and production method |
| 01/28/2009 | CN100455671C Method for biologic preparing 4, 4 dihydric bowel lactone from burdock glycoside |
| 01/28/2009 | CN100455667C Fusion gene vector construction and expression as well as uses |
| 01/28/2009 | CN100455598C Antibody of anti human CD20 from human resources functionally, and application |
| 01/28/2009 | CN100455586C Pyrimidothiophene compounds |
| 01/28/2009 | CN100455585C 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 01/28/2009 | CN100455575C Isoselenothiazolidone compound and its complex and use thereof |
| 01/28/2009 | CN100455568C 6-position substituted indoline, production and use thereof as medicament |
| 01/28/2009 | CN100455566C Novel derivatives of aminocyclohexane |
| 01/28/2009 | CN100455564C Histone de-acetylase inhibitor, preparation and application of pharmaceutical preparations of the same |
| 01/28/2009 | CN100455328C Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 01/28/2009 | CN100455322C A Chinese medicine for treating cancer |
| 01/28/2009 | CN100455301C Therapeutical use of sophora flavescens or sophora subprostrated extracts |
| 01/28/2009 | CN100455293C Method for obtaining an anti-tumor substance from even-toe hoofed mammals |
| 01/28/2009 | CN100455290C Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 01/28/2009 | CN100455289C Anticancer compositions comprising methenamine |
| 01/28/2009 | CN100455284C Compound with P-glycoprotein inhibiting and multidrug-resisting reversing function and its salt |
| 01/28/2009 | CN100455283C Medicine containing acarnine compound as active component |
| 01/27/2009 | US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis |
| 01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482429 cyclic depsipeptides and/or mimetics, used as anticarcinogenic agents, formed by cyclization of polypeptides |
| 01/27/2009 | US7482383 Emulsion containing a plant extract, method for producing said emulsion and for obtaining said plant extract |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482369 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/27/2009 | US7482354 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 01/27/2009 | US7482352 Such as N6-[6-(2-dimethylaminoethylamino)-4-methylsulfanyl-[1,3,5]triazin-2-yl]-2-methylquinoline-4,6-diamine, which stabilizes DNA in G-quadruplex structures (guanine tetrads); anticancer agents |
| 01/27/2009 | US7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482138 PAK5-related compositions and methods |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482007 Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | US7482000 Point mutations; immunology |
| 01/27/2009 | CA2489407C Lasofoxifene tablet and its coating |
| 01/27/2009 | CA2395226C Devices for the delivery of drugs having antiprogestinic properties |
| 01/27/2009 | CA2389280C Triazoles as farnesyl transferase inhibitors |
| 01/27/2009 | CA2388646C Methods and compositions utilizing quinazolinones |
| 01/27/2009 | CA2380783C Human monoclonal antibodies to prostate specific membrane antigen |
| 01/27/2009 | CA2380757C Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 01/27/2009 | CA2378803C Vitamin d3 analogs |
| 01/27/2009 | CA2361605C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 01/27/2009 | CA2354034C Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period |
| 01/27/2009 | CA2342866C Stent coating |
| 01/27/2009 | CA2335115C Fused azepinone cyclin dependent kinase inhibitors |
| 01/27/2009 | CA2309653C Use of protein h as cytostatic agent |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2285040C Death domain containing receptor 5 |
| 01/27/2009 | CA2197319C Lipid analogs for treating viral infections |
| 01/27/2009 | CA2186747C Interleukin-15 |
| 01/27/2009 | CA2173846C Cntf family antagonists |
| 01/22/2009 | WO2009012421A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/22/2009 | WO2009012312A1 Indazoles, benzisoxazoles and benzisothiazoles as inhibitors of protein kinases |
| 01/22/2009 | WO2009012283A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | WO2009012280A2 Benzimidazole poly(adp-ribose)polymerase inhibitors |
| 01/22/2009 | WO2009012268A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 01/22/2009 | WO2009012256A1 Humanized anti-cd79b antibodies and immunoconjugates and methods of use |
| 01/22/2009 | WO2009012156A2 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 01/22/2009 | WO2009012096A2 Improved therapeutic methods and compositions comprising chroman ring compounds |
| 01/22/2009 | WO2009011910A2 Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment |
| 01/22/2009 | WO2009011880A2 Heterocyclic modulators of pkb |
| 01/22/2009 | WO2009011871A2 Thiadiazole modulators of pkb |
| 01/22/2009 | WO2009011850A2 Novel therapeutic compounds |
| 01/22/2009 | WO2009011617A2 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS |
| 01/22/2009 | WO2009010769A1 Pharmaceutical compositions comprising nucleic acids encoding constitutively active toll-like receptors. |
| 01/22/2009 | WO2009010761A1 Dna pk inhibitors |
| 01/22/2009 | WO2009010660A2 Substituted indazoles, the preparation thereof, and use of same in therapeutics |
| 01/22/2009 | WO2009010611A1 Polypeptides derived from psap protein (presenilin 1 - associated protein) capable of causing apoptosis and uses of the same |
| 01/22/2009 | WO2009010542A1 Cyclic amide compounds, method for the production thereof and the use thereof |
| 01/22/2009 | WO2009010530A1 Bicyclic heteroaryl compounds and their use as kinase inhibitors |
| 01/22/2009 | WO2009010479A2 Heterocyclic methylene piperidine derivatives and their use |
| 01/22/2009 | WO2009010409A1 Novel inhibitor of angiogenesis |
| 01/22/2009 | WO2009010299A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 01/22/2009 | WO2009010290A2 Engineered anti-alpha v- integrin hybrid antibodies |